GE compared with VRTX: revenue, margins and what each company keeps, and the suppliers and customers both name

GEGeneral Electric Co

Mkt capRevenueRevenue

VRTXVertex Pharmaceuticals Inc

Mkt capRevenueRevenue

Compare

GEGeneral Electric Co

VRTXVertex Pharmaceuticals Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

2 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±4.8%▼−3.67%×0.77

Q2 FY26±4.6%▼−4.06%×0.89

Q1 FY26±4.2%▼−5.56%×1.33

Jan 22 '26±4.1%▼−7.38%×1.80

VRTX

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±5.2%▲+1.70%×0.33

Q1 FY26±5.4%▼−1.28%×0.24

= impliedGE realized, solidVRTX realized, hatchedOne scale, both sides: full bar = 8%× = |realized| ÷ impliedSource: market data

Feb 13 '26

±6.0%

▲+5.69%

×0.95

Q3 FY25±6.0%▼−1.02%×0.17

GEGeneral Electric Co

313.54▲+3.89%

Mkt cap$311.9BRevenue$14.1BQ3 FY26Revenue$45.9BFY25

VRTXVertex Pharmaceuticals Inc

563.03▲+0.74%

Regular sessionSep 2 '83

Mkt cap$141.7BRevenue$3.3BQ2 FY26Revenue$12.0BFY25

Compare

Regular sessionSep 2 '83

GEGeneral Electric Co

VRTXVertex Pharmaceuticals Inc

313.54▲+3.89%

Price

563.03▲+0.74%

$311.9B

Mkt cap

$141.7B

Q3 FY26$14.1B

Revenue

$3.3BQ2 FY26

FY25$45.9B

Revenue

$12.0BFY25

GE313.54▲+3.89%vsVRTX563.03▲+0.74%Regular sessionSep 2 '83